Conducting Clinical Trials in Poland – Country Profile 2021 Poland is the largest clinical trials market in central and Eastern Europe. Cromos Pharma has been managing clinical research in Poland since 2015 and opened a permanent office in Warsaw in February 2020. WHY POLAND? Strong track record over 20 years of producing high quality data. Large population (38.5 million) in comparison with neighboring countries Read more
Clinical trial of RPH-104 in acute ST-Elevation Myocardial Infarction: Design and Rationale Read the article in the Journal of Translational Medicine co-authored by Dr Vlad Bogin about the study design and its rationale here Cromos Pharma proudly supports the Right2hope nonprofit platform, empowering patients to explore treatment options beyond traditional clinical trials. Through an intuitive, AI-supported matching algorithm, Right2hope connects patients with the most relevant expanded access, Read more
Biosimilars: US and Europe COVID-19 and its economic impacts have only strengthened the case for further developing a sustainable global biosimilars market. In this Insights@CromosPharma paper we explore the development of the European biosimilar market and contrast this with the US. We also look at the key challenges and opportunities facing biosimilar developers. Cromos Pharma proudly supports the Right2hope nonprofit Read more
Clinical characteristics of dermatologic manifestations of COVID‐19 infection This article co-authored by Cromos Pharma CEO Dr Vlad Bogin and published in the International Journal of Dermatology (3 July 2020) examines the dermatologic manifestations of COVID-19. It includes a case series of 15 patients, review of literature, and proposed etiological classification. Read the full article here Cromos Pharma proudly supports the Right2hope nonprofit platform, empowering patients to explore treatment Read more

Schedule a meeting

We are excited to connect with you, understand your goals, and explore how we can support your needs.

Contact us